KNOW RIDGE - Cancer Discoveries

Key enzyme identified as potential target for cancer immunotherapy

Scientists from A*STAR Genome Institute of Singapore (A*STAR GIS) have uncovered that a key enzyme—P4HA1 prolyl hydroxylase, is strongly induced in CD8+ T cells in solid cancer, the primary immune cells involved in combating cancer. P4HA1 causes disruptions in energy production within the cells, which leads to weaker immune cells that are less able to fight cancer and form long-lasting anti-cancer immunity, highlighting P4HA1 as a promising target for treating solid tumors.

The #1 Cancer-Fighting Food To Eat Because It ‘Slows Tumor Growth’ And Blocks Its Ability To Spread, Health Expert Reveals | SHEfinds

Cancer is a complex disease characterized by the uncontrolled growth of abnormal cells in the body.

BeiGene wins US nod for Tevimbra label expansion (BGNE:NASDAQ) | Seeking Alpha

BeiGene (BGNE) has received U.S. FDA approval for its cancer drug Tevimbra in combination with chemotherapy for certain gastric carcinoma. Read more here.

Press release for research from the 2024 ASTRO Annual Meeting

IMRT and proton therapy offer equally high quality of life and tumor control for people with prostate cancer – American Society for Radiation Oncology (ASTRO)

Zai Lab stock rises on Tivdak trial data (ZLAB:NASDAQ) | Seeking Alpha

Zai Lab (ZLAB) stock rose after positive trial data for its cervical cancer drug Tivdak and its plans to seek marketing approval for the drug in China. Read more here.

New hope for treating blood cancers using a breast cancer drug

Two recent studies from researchers at Washington University School of Medicine in St. Louis have identified a promising way to treat certain blood cancers using a drug originally developed for breast cancer. These findings could potentially change how doctors approach the treatment of these challenging diseases. The studies focused on a group of blood cancers […]

New drug combo offers hope for liver cancer patients

Researchers at Mount Sinai have achieved a significant breakthrough in treating hepatocellular carcinoma (HCC), the most common type of liver cancer. Led by Dr. Josep M. Llovet, Professor of Medicine at the Icahn School of Medicine at Mount Sinai, the team tested a combination of treatments that could help patients live longer without their cancer […]

This test can reduce lung cancer deaths

What supplements help with cancer prevention?

Many people look to supplements to help reduce their risk of cancer, but with so many options available, it can be hard to know what actually works. While no pill or powder can guarantee protection against cancer, research suggests that certain vitamins, minerals, and plant-based compounds may play a role in prevention. Let’s take a […]